Skip to main content
Robert Bohl, MD, Urology, Edenton, NC

RobertDanielBohlMDFACS

Urology Edenton, NC

R. Daniel Bohl, Urologist

Dr. Bohl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bohl's full profile

Already have an account?

  • Office

    222 Virginia Rd
    Ste B
    Edenton, NC 27932
    Phone+1 252-482-2210
    Fax+1 252-482-2257

Summary

  • For full information, visit www.rdanielbohl.com

Education & Training

  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Urology, 1977 - 1980
  • University of Cincinnati Medical Center
    University of Cincinnati Medical Center1974 - 1977
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1974
  • Denison University
    Denison UniversityBA, Chemistry, Summa Cum Laude, Phi Beta Kappa, 1966 - 1970

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2007 - 2025
  • OH State Medical License
    OH State Medical License 1975 - 2009
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Journal Articles

  • Maintenance versus Non-maintenance of Superficial Bladder Cancer: A Southwest Oncology Group Study.  
    Lamm, D.L., Sarosdy, M.F., Grossman, H.B., Bohl, R.D, Hatch, T., Moon, T.D., Crawford, E.D., Lowe, B.E., Weems, W.L., Blumenstein, B., Crissman, J., Beck, T.M., Montie..., Journal of Urology, 143:341 (610)
  • Maintenance BCG Immunotherapy of the Superficial Bladder Cancer: a randomized prospective Southwest Oncology Group Study.  
    Lamm, D.L., Crawford, E.D., Blumenstein, B., Crissman, J., Montie, J., Gottesman, J., Lowe, B., Sarosdy, M.F., Bohl, R.D., Weems, W.L., Grossman, H.B., Beck, T.M., Lei..., Journal of Urology, 147:4 (242)
  • Maintenance Bacillus Calmete-Guerin Immunotherapy for Recurrent Ta,T1, and Carcinoma in Situ Transitional Cell Carcinoma of the Bladder: a Randomized Southwest Oncolog...  
    Lamm, D.L., Crawford, E.D., Blumenstein, B., Crissman, J., Montie, J., Gottesman, J., Lowe, B., Sarosdy, M.F., Bohl, R.D., Weems, W.L., Grossman, H.B., Beck, T.M., Le..., Journal of Urology, 163, 1124-1129